Harvard Gastroenterology 2026

• Include:  videos + file sub vtt +  pdf, size:  GB
• Target Audience: internists, hospitalists, primary care physicians, gastroenterologists, hepatologists, oncologists, geriatricians, and obstetricians/gynecologists
• Sample video: contact me for sample video
• Information:

1. Overview

The Comprehensive 2026 Gastroenterology Update

Gastroenterology 2026 is a live online course, using live streaming, electronic Q&A, and other remote learning technologies.

This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.

Practical, Results-Driven Education

Highlights of the 2026 program include:

The newest guidelines for the use of biologics in IBD

Therapeutic drug monitoring in IBD treatment

Management of the older adult with IBD

Updated guidelines for treatment of C. difficile infection

Managing GI complications of immunotherapy and anti-neoplastic therapies

Improved management of IBS

Tips for managing fecal incontinence

Management of refractory GERD

Optimal surveillance in hereditary GI cancer syndromes

Current treatment of H. pylori

Updated treatment of HBV and HCV

Management of steatotic liver disease in 2026

How to diagnose and manage cirrhosis

How to improve your adenoma detection rate (ADR)

Steps to ensure delivery of high-quality colonoscopic care

Techniques to effectively control acute GI bleeding

Endoscopic management of obesity

When FMT is indicated for treatment

New strategies to treat common GI problems

A comprehensive update of national guidelines

Education to Optimize Your Patient Outcomes

The evidence-based recommendations provided in this program cover strategies to improve care and outcomes for patients with:

IBD

GI complications of immunotherapy

Microscopic colitis

Steatotic liver disease

Barrett’s esophagus

Eosinophilic esophagitis

C. difficile colitis

H. pylori infection

Alcohol-related liver disease

Autoimmune hepatitis

IBS

Refractory GERD

Acute pancreatitis

Chronic pancreatitis

Celiac disease

GI bleeding

High risk for colorectal cancer

Recent Advances and Innovations

Clinicians can rely on this program for education on:

Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?

GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?

Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?

The stool microbiome: understanding the science behind clinical applications

Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon

Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate

Endoscopic approaches to managing obesity

Updated treatments for HBV and HCV

This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.

2. Learning Objectives Upon completion of this course, participants will be able to:

Interpret major advances in the field of gastroenterology.

Incorporate the most up-to-date diagnostic approaches to GI disorders.

Identify therapeutic options for GI disorders in an evidence-based manner.

Manage patients with both common and rare GI disorders using established guidelines.

3. Target Audience Who Should Participate:

Gastroenterologists

Internists

Hospitalists

Surgeons

Nurse Practitioners

Physician Assistants …and other medical professionals seeking a comprehensive update in Gastroenterology.

Best for internists, hospitalists, primary care physicians, gastroenterologists, hepatologists, oncologists, geriatricians, and obstetricians/gynecologists.

4. Topics

Monday, June 8, 2026

Welcome

Dr. Daniel Chung

Which Initial Therapy to Choose in Crohn’s Disease?

Dr. Joshua Korzenik

Which Initial Therapy to Choose in Ulcerative Colitis?

Dr. Ashwin Ananthakrishnan

Putting It Together: Illustrative IBD Case Presentations

Dr. Kristin Burke

Panel Q&A

Drs. Ashwin Ananthakrishnan, Joshua Korzenik, and Kristin Burke

Break

Management of the Older Adult with IBD

Dr. Bharati Kochar

IBD in Pregnancy

Dr. Loren Rabinowitz

Therapeutic Drug Monitoring in IBD

Dr. Adam Cheifetz

Panel Q&A

Drs. Adam Cheifetz, Bharati Kochar, and Loren Rabinowitz

Break

How to Manage Microscopic Colitis

Dr. Hamed Khalili

GI Complications of Immunotherapy

Dr. Michael Dougan

GI Complications of Antineoplastic Therapy

Dr. Shilpa Grover

Panel Q&A

Drs. Michael Dougan, Hamed Khalili, and Shilpa Grover

Break

High-Risk Cancer Surveillance in GI Cancer Syndromes

Dr. Daniel Chung

CRC Screening and How to Improve Your ADR

Dr. Ramona Lim

Beyond Screening: What to Recommend to Reduce Colorectal Cancer Risk

Dr. Andrew Chan

Panel Q&A

Drs. Daniel Chung, Ramona Lim, and Andrew Chan

Day 2

Tuesday, June 9, 2026

Barrett’s Esophagus: Whom and How to Treat?

Dr. Douglas Pleskow

Esophageal Motility Disorders Made Easy

Dr. Barbara Nath

Management of Refractory GERD

Dr. Norman Nishioka

Panel Q&A

Drs. Douglas Pleskow, Barbara Nath, and Norman Nishioka

Break

Comprehensive Approach to Eosinophilic Esophagitis

Dr. Walter Chan

Celiac Disease and Gluten Sensitivity: 2026 Practitioner Updates

Dr. Ciaran Kelly

Panel Q&A

Drs. Walter Chan and Ciaran Kelly

Break

Making the Diagnosis of IBS

Dr. Kyle Staller

Modern Strategies to Treat IBS

Dr. Vikram Rangan

Tips to Managing Fecal Incontinence

Dr. Kyle Staller

Panel Q&A

Drs. Kyle Staller and Vikram Rangan

Break

Optimizing the Management of Gastroparesis

Dr. Trisha Pasricha

How to Evaluate Small Intestinal Bacterial Overgrowth

Dr. Judy Nee

Panel Q&A

Drs. Judy Nee and Trisha Pasricha

Day 3

Wednesday, June 10, 2026

Cholestatic Liver Diseases: What’s New in PBC and PSC

Dr. Daniel Pratt

Update on Autoimmune Hepatitis

Dr. Alan Bonder

Current Approaches to the Treatment of HBV and HCV

Dr. Michael Curry

Panel Q&A

Drs. Daniel Pratt, Alan Bonder, and Michael Curry

Break

Alcohol-Associated Liver Disease

Dr. Gyongyi Szabo

The Management of MASLD

Dr. Kathleen Corey

Panel Q&A

Drs. Gyongyi Szabo and Kathleen Corey

Break

How to Workup a Liver Lesion

Dr. Karin Andersson

Diagnosis and Routine Management of Cirrhosis

Dr. Michelle Lai

Managing Advanced Liver Disease

Dr. Anna Rutherford

Panel Q&A

Drs. Anna Rutherford and Karin Andersson

Break

Best Management Strategies in Acute Pancreatitis

Dr. David Jin

Updates in Chronic Pancreatitis

Dr. Sunil Sheth

Controversies in the Management of Cystic Lesions of the Pancreas

Dr. Carlos Fernandez-del Castillo

Panel Q&A

Drs. David Jin, Sunil Sheth, and Carlos Fernandez-del Castillo

Day 4

Thursday, June 11, 2026

Tips to Removing the Difficult Colon Polyp

Dr. Tyler Berzin

Quality in Colonoscopy: What to Measure and Why It Matters

Dr. Mandeep Sawhney

Endoscopy and the Anticoagulated Patient

Dr. Kunal Jajoo

Panel Q&A

Drs. Tyler Berzin, Mandeep Sawhney, and Kunal Jajoo

Break

Acute GI Bleeding and Other GI Emergencies

Dr. Linda Lee

Advances in Endoscopic Surgery for Foregut Disorders

Dr. Kumar Krishnan

Endoscopic Approaches to Manage Obesity

Dr. Christopher Thompson

Panel Q&A

Drs. Christopher Thompson, Kumar Krishnan, and Linda Lee

Break

What’s New in C. Difficile Colitis

Dr. Jessica Allegretti

Q&A with Dr. Allegretti

New Insights into the Gut Microbiome and Disease

Dr. Ramnik Xavier

Current Approach to Diagnosis and Treatment of Helicobacter pylori

Dr. Jay Luther

GI Cases to Remember

Dr. Douglas Horst

Panel Q&A

Drs. Douglas Horst, Ramnik Xavier, and Jay Luther